
Agoxin0.25 mg
Aristopharma Ltd.
Digoxin is a cardiac glycoside indicated for the following conditions: Heart failure (established/FDA-approved use): Used to improve symptoms and reduce the need for hospitalization in adults with…
Digoxin is a cardiac glycoside indicated for the following conditions:
Digoxin is not indicated for ventricular arrhythmias and is not a first-line agent for acute heart failure or for rhythm control (conversion to normal sinus rhythm) of atrial fibrillation.
| Indication | Typical Dosing |
|---|---|
| Heart failure (maintenance) | 0.125 mg to 0.25 mg orally once daily; lower doses (0.0625 mg to 0.125 mg daily) are often used in elderly patients or those with renal impairment. |
| Atrial fibrillation (rate control) | Loading ("digitalization") is rarely used today; when needed, it is given under close monitoring, followed by a maintenance dose similar to that used in heart failure, individualized using serum Digoxin concentration and clinical response. |
Pediatric dosing of Digoxin is weight- and age-based and must be individualized by a pediatric cardiologist or specialist; per-kilogram doses are generally higher in neonates and infants than in older children and adults, reflecting differences in drug distribution. Safety and efficacy have been established for use in pediatric heart failure and certain supraventricular arrhythmias under specialist supervision; Digoxin should not be dosed in children without specialist guidance.
Digoxin is cleared predominantly by the kidneys, so patients with renal impairment require lower doses and closer monitoring of serum Digoxin concentration, renal function, and electrolytes to avoid accumulation and toxicity.
No specific dose adjustment is generally required for hepatic impairment, since Digoxin undergoes minimal hepatic metabolism; however, clinical monitoring is still advised.
Side effects of Digoxin are often dose-related and closely tied to serum drug concentration:
Patients should seek prompt medical attention if they notice visual changes, irregular heartbeat, severe nausea/vomiting, or confusion while taking Digoxin.
Digoxin is contraindicated in:
Additional situations that amount to a near-contraindication and generally warrant avoiding Digoxin unless directed by a cardiac specialist include Wolff-Parkinson-White syndrome with atrial fibrillation (risk of accelerated conduction through an accessory pathway) and certain high-grade atrioventricular blocks in the absence of a pacemaker; see Precautions and Warnings for details.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.